TAC. ARV’s in our lives. A handbook for people living with HIV and treatment advocates in support groups, clinics and communities (http://www.tac.org.za/documents/arvsinourlives.pdf).
 Berger JR et al. Cranial neuropathy heralding otherwise occult AIDS-related large cell lymphoma. J Clin Neuroophthalmol 13: 113-18, 1993.
 Enting RH, Essenlink RA, Portegies R. Lymphomatous meningitis in AIDS-related systemic non-Hodgkin’s lymphoma: a report of eight cases. J Neurol Neurosurg Psychiatry 57:150-3, 1994.
 Andersson MI, Willcox PA. Tuberculous tenosynovitis and carpal tunnel syndrome as a presentation of HIV disease. J Infect.;39(3):240-1, 1999.
 Orrell R et al. Peripheral nerve granuloma in a patient with tuberculosis. J Neurol Neurosurg Psychiatry. 73(6): 769–771, 2002.
 Hernando I et al. Sensory-motor polyneuropathy associated with lung tuberculosis: presentation of two new cases]. Rev Neurol. 24(131):841-2, 1996.
 Nagel MA, Gilden DH. The protean neurologic manifestations of varicella-zoster virus infection. Cleve Clin J Med. 74(7):489-94, 496, 498-9, 2007. (available online)
 Mueller NH et al. Varicella zoster virus infection: clinical features, molecular pathogenesis of disease, and latency. Neurol Clin ;26(3):675-97, viii, 2008.
 Caniello M et al. Confluent peripheral multiple mononeuropathy associated to acute hepatitis B: a case report. Rev Inst Med Trop Sao Paulo;44(3):171-3, 2002.
 Heckmann JG et al. Neurological manifestations of chronic hepatitis C. J Neurol;246(6):486-91, 1999.
 Boukhris S et al. Polyneuropathy with demyelinating features in mixed cryoglobulinemia with hepatitis C virus infection. Eur J Neurol. ;13(9):937-41, 2006.
 Louis E et al. Bilateral amyotrophic neuralgia (Parsonage Turner syndrome) with HIV seroconversion. Rev Neurol (Paris)159(6-7 Pt 1):685-7, 2003.
 Calabrese LH et al. Acute infection with the human immunodeficiency virus (HIV) associated with acute brachial neuritis and exanthematous rash. Ann Intern Med 107:849-51, 1987.
 Said G, Lacroix C. Primary and secondary vasculitic neuropathy. J Neurol 252:633-41, 2005.
 Lipkin WI et al. Inflammatory neuropathy in homosexual men with lymphadenopathy. Neurology 35:1479-83, 1985.
 Serrano P et al. Bilateral Bell palsy and acute HIV type 1 infection: report of 2 cases and review. Clin Infect Dis.;44(6):e57-61, 2007.
 Bélec L et al. Peripheral facial paralysis and HIV infection: report of four African cases and review of the literature. J Neurol. 236(7):411-4, 1989.
 Murr AH, Benecke JE Jr. Association of facial paralysis with HIV positivity. Am J Otol. 12(6):450-1, 1991.
 Roullet E et al. Cytomegalovirus multifocal neuropathy in AIDS: analysis of 15 consecutive cases. Neurology 44:2174-82, 1994.
 McCutchan JA. Clinical impact of cytomegalovirus infections of the nervous system in patients with AIDS. Clin Infect Dis 21 (Suppl 2):S196-201, 1995.
 Fuller GN. Cytomegalovirus and the peripheral nervous system in AIDS. J Acquir Immune Defic Syndr 5(Suppl 1):S33-6, 1992.
 Kolson DL, Gonzalez-Scarano F. HIV-associated neuropathies: role of HIV-1, CMV, and other viruses. J Peripher Nerv Syst 6:2-7, 2001.
 Said G et al. Cytomegalovirus neuropathy in acquired immunodeficiency syndrome: a clinical and pathological study. Ann Neurol 29:139-46, 1991.
 Kim YS et al. Polyradiculopathy due to cytomegalovirus: Report of two cases in which improvement occurred after prolonged therapy and review of the literature. Clin Infect Dis 17:32-37, 1993.
 Miller RF et al. Acute lumbosacral polyradiculopathy due to cytomegalovirus in advanced HIV disease: CSF findings in 17 patients. J Neurol Neurosurg Psychiatry 61(5):456-60, 1996. (free online download).
 Winston A, Marriott D, Brew B. Early syphilis presenting as a painful polyradiculopathy in an HIV positive individual. Sex Transm Infect 81(2):133-4 2005.
 Tajima Y, Sudo K Matumoto A, Malignant lymphoma originating in the cauda equina mimicking the Inflammatory polyradiculoneuropathy . Intern Med 46: 1029-1032, 2007. Free online download.
 Léger JM et al. Lymphoma-induced polyradiculopathy in AIDS: two cases. J Neurol 239(3):132-4, 1992.
 Cornblath DR, McArthur JC. Predominant sensory neuropathy in patients with AIDS and AIDS related complex. Neurology 38:794-6, 1988.
 Cornblath DR, Griffin GW, Tennekoon, FI. Immunoreactive myelin basic protein in cerebrospinal fluid of patients with peripheral neuropathies. Ann Neuol 20:370-372, 1986.
 Thornton CA, Latif AS, Emmanuel JC. Guillain-Barré syndrome associated with human immunodeficiency virus infection in Zimbabwe. Neurology. 41(6):812-5, 1991.
 Simpson, D et al. HIV-associated neuromuscular weakness syndrome. AIDS. 18(10):1403-12, 2004.
 Vidal JE et al. HIV-associated neuromuscular weakness syndrome in Brazil: report of the two first cases. Arq Neuropsiquiatr;65(3B):848-51, 2007.
Fredericks, EJ; Kugelman, TP; Kirsch, N. Dapsone-induced motor polyneuropathy. A complication of prolonged treatment of subcorneal pustular dermatosis. Arch Dermatol 112(8):1158–1160, 1976.
 Gutmann, L; Martin, JD; Welton, W. Dapsone motor neuropathy--an axonal disease. Neurology. Jun;26(6 Pt 1):514–516, 1976.
 Ahrens EM, Meckler RJ, Callen JP.Dapsone-induced peripheral neuropathy. Int J Dermatol 25(5):314-6, 1986.
 Keswani SC et al. The spectrum of peripheral neuropathies in AIDS. in The Neurology of AIDS, Editors, Gendelman HE et al. Edition: 2, illustrated, Oxford University Press, 2005.
 Verma S, Simpson DM. Peripheral neuropathy in HIV infection. Handb Clin Neurol ;85:129-37, 2007.
 Keswani, op cit.
 Spudich SS, Price RW. Neurological disease, in AIDS Therapy, 3rd Edition, Editors Dolan R, Masur H, Saag M. Churchill Livingstone, Elsevier Inc, 2008.
 Wu G et al. Early onset of spontaneous activity in uninjured C-fiber nociceptors after Injury to neighboring nerve fibers. The Journal of Neuroscience, 21:RC140:1-5, 2001.
 From, Brown RC et al. HIV/AIDS. Clinical Case Studies. 101 Cases for Training Clinical Staff. Nanasi, 2006.
 Dalakas MC. Peripheral neuropathy and antiretroviral drugs. J Periph. Nerv. Syst. 6: 14-20, 2001.
 Simpson DM, Tagliati M. Nucleoside analogue-associated peripheral neuropathy in human immunodeficiency virus infection. J Acquir Immune Defic Syndr Hum Retrovirol 9(2):153-61, 1995.
 Spudich, Price. Op cit.
 Keswani, op cit.
 Koike H, Sobue G. Alcoholic neuropathy. Curr Opin Neurol;19(5):481-6, 2006.
 Koike H et al. Alcoholic neuropathy is clinicopathologically distinct from thiamine-deficiency neuropathy. Annals of Neurology, 54:1, 19 – 29, 2003.
 Williams FH. Neuromuscular complications of nutritional deficiencies. Phys Med Rehabil Clin N Am. 19(1):125-48, vii, 2008.
 Vinik AI, Mehrabyan A. Diabetic neuropathies.Med Clin North Am. 88(4):947-99, xi, 2004.
 Said G. Focal and multifocal diabetic neuropathies. Arq Neuropsiquiatr;65(4B):1272-8, 2007 (available online)
 Said G. Leprous neuropathy. In: Mendell JR, Kissel JT, Cornblath DR, eds. Diagnosis and management of peripheral nerve disorders. Oxford University Press: 551–64, 2001.
 Agrawal A et al. Neurological manifestations of Hansen's disease and their management. Clin Neurol Neurosurg. 107(6):445-54, 2005.
 Ooi WW, Srinivasan J. Leprosy and the peripheral nervous system: basic and clinical aspects. Muscle Nerve. 30(4):393-409, 2004.
 Grimaud J, Vallat JM. [Neurological manifestations of leprosy [in French] Rev Neurol (Paris).159(11):979-95, 2003.
 Verma, Simspon, Op cit.
 Griffin JW et al. Predominantly sensory neuropathy in AIDS: distal axonal degeneration and unmyelinated fiber loss [abstract]. Neurology. 1991;41(suppl 1):374. Abstract 900S, 1991.
 Wiley CA. Neuromuscular diseases of AIDS. The FASEB Journal 3: 2503-2511, 1989.
 Verma, Simspon, op cit.
 Moyle GJ, Sadler M. Peripheral neuropathy with nucleoside antiretrovirals: risk factors, incidence and management. Drug Saf 19:481-494, 1998.
 Fichtenbaum CJ, Clifford DB, Powderly WG. Risk factors for dideoxynucleoside-induced toxic neuropathy in patients with the human immunodeficiency virus infection. J Acquir Immune Defic Syndr Hum Retrovirol 10:169-174, 1995.
 So YT et al. Peripheral neuropathy associated with acquired immunodeficiency syndrome. Prevalence and clinical features from a population-based survey. Arch Neurol 45(9):945-8, 1988.
 Schifitto G et al; Dana Consortium on the Therapy of HIV Dementia and Related Cognitive Disorders. Incidence of and risk factors for HIV-associated distal sensory polyneuropathy. Neurology. 58(12):1764-8, 2002.
 Heaton R et al. HIV-associated neurocognitive impairment remains prevalent in the era of combination ART: the CHARTER study. 16th Conference on Retroviruses and Opportunistic Infections, Montréal, abstract 154, 2009.
 Ellis RJ et al. Persisting high prevalence of HIV distal sensory peripheral neuropathy in the era of combination ART: correlates in the CHARTER study. 16th Conference on Retroviruses and Opportunistic Infections, Montréal, abstract 461, 2009.
 Evans SR et al. HIV-Associated peripheral neuropathy in the HAART era: results from AIDS Clinical Trials Group (ACTG) Longitudinal Linked Randomized Trials (ALLRT) Protocol A5001. 16th Conference on Retroviruses and Opportunistic Infections, Montréal, abstract 462, 2009.
 Lichtenstein KA, Armon C, Baron A, et al, for the HIV Outpatient Study Investigators. Modification of the incidence of drug-associated symmetrical peripheral neuropathy by host and disease factors in the HIV Outpatient Study cohort. Clin Infect Dis. 40:148-157, 2005.
 Kallianpur AR et al. Hemochromatosis (HFE) gene mutations and peripheral neuropathy during antiretroviral therapy. AIDS 20(11)13 p 1503-1513, 2006.
 Costarelli S et al. No evidence of relation between peripheral neuropathy and presence of hemochromatosis gene mutations in HIV-1-positive patients. JAIDS 46(2)1 255-256, 2007.
 Cherry C et al. Cytokine genotype suggests a role for inflammation in nucleoside analog-associated sensory neuropathy (NRTI-SN) and predicts an individual's NRTI-SN risk. AIDS Research and Human Retroviruses. 24(2): 117-123, 2008.
 Hulgan T et al. Hemochromatosis gene polymorphisms, mitochondrial haplogroups and peripheral lipoatrophy during antiretroviral therapy. J Inf Dis197:858–866, 2008.
 Canter J et al. Mitochondrial sub-haplogroups and peripheral neuropathy during ART among non-Hispanic Black participants in AIDS Clinical Trials Group Study 384. 16th Conference on Retroviruses and Opportunistic Infections, Montréal, abstract 160, 2009.
 Hulgan T et al. Mitochondrial haplogroups and peripheral neuropathy during antiretroviral therapy: an adult AIDS clinical trials group study. AIDS 19: 1341-1349, 2005.
 Mielke J. Peripheral nerve disease in HIV infected subjects, 2006. An African perspective. The Second assessment of NeuroAIDS in Africa. Arusha, Tanzania, 2006.
 Parry, O et al. Peripheral neuropathy in individuals with HIV infection in Zimbabwe. Acta Neurologica Scandanavica 96(4) 218-222, 1997.
 Nakasujja N et al. Human immunodeficiency virus neurological complications: an overview of the Ugandan experience. J Neurovirol;11 Suppl 3:26-9, 2005.
 Sacktor N et al. Benefits and risks of stavudine therapy for HIV-associated neurologic complications in Uganda. Neurology;72(2):165-70, 2009.
 Forna F et al. Clinical toxicity of highly active antiretroviral therapy in a home-based AIDS care program in rural Uganda J Acquir Immune Defic Syndr 2007;44:456–462, 2007.
 Birbeck GL, Am. J. Trop. Med. Hyg., in press.
 Boulle A et al. Substitutions due to antiretroviral toxicity or contraindication in the first 3 years of antiretroviral therapy in a large South African cohort. Antivir Ther. 12(5): 753-60, 2007.
 Hitchcock SA, Meyer HP, Gwyther E. Neuropathic pain in AIDS patients prior to antiretroviral therapy. SAMJ 98 (11), 2008.
 Van Dyke RB et al. Toxicities associated with dual nucleoside reverse-transcriptase inhibitor regimens in HIV-infected children. J Infect Dis 198:1599–608, 2008.
 Sithinamsuwan P et al. Frequency and characteristics of HIV-associated sensory neuropathy among HIV patients in Bangkok, Thailand. J Acquir Immune Defic Syndr 49(4), 2008.
 Cherry C et al. Predicting neuropathy risk before stavudine prescription: an algorithm for minimizing neurotoxicity in resource-limited settings. 16th Conference on Retroviruses and Opportunistic Infections, Montréal, abstract 161, 2009.